| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_394d01be12f4dcb9db948c09e3fa48d4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-494 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 |
| filingDate |
2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880c9b4b3ecc8d78f3a3b81deb613360
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3953c7f58173f55612005fbd4276a77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faa493bfd602662619a82a538a9e1931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7542c3b13c0562cfc68ac47de1b17b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a6785913695a1aa3b97e938316e44e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9532c41a5b51caf9cee391bf1c8f81ff |
| publicationDate |
2004-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20040007044-A |
| titleOfInvention |
Composition including antifungal-agents of external application for skin-whitening and external application having the same |
| abstract |
Disclosed is a skin whitening external preparation comprising an antifungal agent having an action of inhibiting melanin production and tyrosinase activity as an active ingredient, and an external preparation for skin whitening described above. Provided is an external preparation for skin whitening containing 0.001 to 5.00 wt% of an antifungal agent and an external preparation for skin whitening comprising such an active ingredient. The anti-fungal clotrimazole, biponazole, methyl isothiazolinone, sulfonazole, and itraconazole effect on the melanin production and the new use as a whitening agent through the inhibition of tyrosinase have the effect of whitening and melanin production. It is possible to provide an excellent external preparation composition for skin whitening and safety and excellent side effects and external preparations containing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009331298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017007999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110098839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102264357-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102264357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2845587-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I480055-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010074052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2537186-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3009123-A1 |
| priorityDate |
2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |